Rafia Bhore
About
Rafia Bhore is a scholar working on Hepatology, Oncology and Epidemiology.
According to data from OpenAlex, Rafia Bhore has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 17 papers in Oncology and 15 papers in Epidemiology. Recurrent topics in Rafia Bhore's work include Hepatitis C virus research (16 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Liver Disease Diagnosis and Treatment (8 papers). Rafia Bhore is often cited by papers focused on Hepatitis C virus research (16 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Liver Disease Diagnosis and Treatment (8 papers). Rafia Bhore collaborates with scholars based in United States, Germany and Italy. Rafia Bhore's co-authors include Asunción Mejías, Jedd D. Wolchok, Margaret Trost, Alejandra Soriano‐Fallas, Octavio Ramilo, Michael A. Postow, Dirk Schadendorf, James Larkin, Damian Walker and Caroline Robert and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Rafia Bhore
54 papers receiving 1.9k citations
Peers
Rafia Bhore
Marta Piqueras Spain
Cheng‐Hwai Tzeng Taiwan
Christopher P. Fox United Kingdom
Mariele Gatto Italy
Anne Huynh France
P. Ghillani France
Zhuoli Zhang China
Gilles Boire Canada
Angela Ceribelli Italy
Hisashi Tateyama Japan
Citations per year, relative to Rafia Bhore Rafia Bhore (= 1×)
peers
Marta Piqueras
Countries citing papers authored by Rafia Bhore
Since
Specialization
Citations
This map shows the geographic impact of Rafia Bhore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafia Bhore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafia Bhore more than expected).
Fields of papers citing papers by Rafia Bhore
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Rafia Bhore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafia Bhore. The network helps show where Rafia Bhore may publish in the future.
Co-authorship network of co-authors of Rafia Bhore
This figure shows the co-authorship network connecting the top 25 collaborators of Rafia Bhore. A scholar is included among the top collaborators of Rafia Bhore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafia Bhore. Rafia Bhore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Somersan-Karakaya, Selin, Eleftherios Mylonakis, Ernesto Oviedo‐Orta, et al.. (2023). Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double–Blind Trial. Open Forum Infectious Diseases. 10(5). ofad211–ofad211.
2.
Spigel, David R., Robert M. Jotte, Santiago Ponce Aix, et al.. (2020). Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non–Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial. Clinical Lung Cancer. 22(1). 6–15.e4.
3.
Goldman, Jonathan W., David Waterhouse, Ben George, et al.. (2019). Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer. Frontiers in Oncology. 9. 1256–1256.
4.
Sahai, Vaibhav, Aparna Kalyan, Philip A. Philip, et al.. (2019). A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab -Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer. SHILAP Revista de lepidopterología. 5(1). 35–42.
5.
Spigel, David R., Robert M. Jotte, Santiago Ponce Aix, et al.. (2018). nab-paclitaxel + carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND.sqm study. Annals of Oncology. 29. viii749–viii750.
6.
Robert, Caroline, James Larkin, Paolo A. Ascierto, et al.. (2017). Characterization of complete responses (CRs) in patients with advanced melanoma (MEL) who received the combination of nivolumab (NIVO) and ipilimumab (IPI), NIVO or IPI alone. Annals of Oncology. 28. v428–v428.
7.
Grob, Jean‐Jacques, Dirk Schadendorf, John Wagstaff, et al.. (2017). Regional differences in overall survival (OS) in patients with advanced melanoma (MEL) who received nivolumab (NIVO) combined with ipilimumab (IPI) or NIVO alone in a phase 3 trial (CheckMate 067). Annals of Oncology. 28. v432–v433.
8.
Luetkemeyer, Anne F., Cheryl McDonald, Moti Ramgopal, et al.. (2016). 12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens. Clinical Infectious Diseases. 62(12). 1489–1496.
9.
McPhee, Fiona, Yoshiyuki Suzuki, Joji Toyota, et al.. (2015). High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms. Advances in Therapy. 32(7). 637–649.
10.
Kowdley, Kris V., Daniel Nelson, Jacob Lalezari, et al.. (2015). P0829 : On-treatment HCVRNA as a predictor of sustained virologic response in HCV genotype 3 infected patients treated with daclatasvir and sofosbuvir: analysis of phase 3 ALLY-3 study. Journal of Hepatology. 62. S648–S648.
11.
Luetkemeyer, Annie, Cheryl McDonald, Moti Ramgopal, et al.. (2015). 12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV/HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens. Open Forum Infectious Diseases. 2(suppl_1).
12.
Melo, Wanderley José de, Rafia Bhore, & Don C. Rockey. (2013). Clinical Judgment Does Not Circumvent the Need for Diagnostic Endoscopy in Upper Gastrointestinal Hemorrhage. Journal of Investigative Medicine. 61(8). 1146–1151.
13.
Soon, Guoxing, Min Min, Kimberly Struble, et al.. (2012). Meta-Analysis of Gender Differences in Efficacy Outcomes for HIV-Positive Subjects in Randomized Controlled Clinical Trials of Antiretroviral Therapy (2000–2008). AIDS Patient Care and STDs. 26(8). 444–453.
14.
Jain, Mamta K., Emmanuel Seremba, Rafia Bhore, et al.. (2012). Change in Fibrosis Score as a Predictor of Mortality Among HIV-Infected Patients with Viral Hepatitis. AIDS Patient Care and STDs. 26(2). 73–80.
15.
Chang, Michael, Alejandro Jordán-Villegas, Amanda S. Evans, et al.. (2012). Respiratory Viruses Identified in an Urban Children’s Hospital Emergency Department During the 2009 Influenza A(H1N1) Pandemic. Pediatric Emergency Care. 28(10). 990–997.
16.
Bhore, Rafia, et al.. (2011). The Hematocrit Level in Upper Gastrointestinal Hemorrhage: Safety of Endoscopy and Outcomes. The American Journal of Medicine. 124(10). 970–976.
17.
Erdman, William, et al.. (2010). Effectiveness of technetium labeled leukocytes SPECT CT imaging in patients with nonspecific or clinically incongruent MRI scans. The Science of The Total Environment. 51. 1631–1631.
18.
Stoll, Matthew L., Rafia Bhore, Molly Dempsey, & Marilynn Punaro. (2010). Spondyloarthritis in a Pediatric Population: Risk Factors for Sacroiliitis. The Journal of Rheumatology. 37(11). 2402–2408.
19.
Schorge, John O., et al.. (2009). Secondary cytoreductive surgery for recurrent platinum‐sensitive ovarian cancer. International Journal of Gynecology & Obstetrics. 108(2). 123–127.
20.
Tripathi, Manjari, P. Sarat Chandra, Rajeev Yadav, et al.. (2009). Cardiovascular autonomic functions in well-controlled and intractable partial epilepsies. Epilepsy Research. 85(2-3). 261–269.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Marta Piqueras Breakdown of academic impact, for papers by Cheng‐Hwai Tzeng Breakdown of academic impact, for papers by Christopher P. Fox Breakdown of academic impact, for papers by Mariele Gatto Breakdown of academic impact, for papers by Anne Huynh Breakdown of academic impact, for papers by P. Ghillani Breakdown of academic impact, for papers by Zhuoli Zhang Breakdown of academic impact, for papers by Gilles Boire Breakdown of academic impact, for papers by Angela Ceribelli Breakdown of academic impact, for papers by Hisashi Tateyama